Deregulation of translation due to post-transcriptional modification of rRNA explains why erm genes are inducible

Nature Communications

Volumn 4, Issue , 2013, Pages

  Gupta, Pulkit ^a   Sothiselvam, Shanmugapriya ^a   Vázquez Laslop, Nora ^a   Mankin, Alexander S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN RESISTANCE METHYLTRANSFERASE; METHYLTRANSFERASE; NUCLEOTIDE; PROTEOME; RIBOSOME RNA; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; PEPTIDE; RRNA (ADENOSINE O 2' )METHYLTRANSFERASE; RRNA (ADENOSINE-O-2'-)METHYLTRANSFERASE;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DEMETHYLATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RIBOSOME; STAPHYLOCOCCUS AUREUS; BACTERIAL GENE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHYLATION; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; RNA PROCESSING;

BACTERIA (MICROORGANISMS);

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BASE SEQUENCE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; METHYLATION; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BIOSYNTHESIS; RIBOSOMES; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, RIBOSOMAL; STAPHYLOCOCCUS AUREUS;

EID: 84890158770     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2984     Document Type: Article

References (60)

1. Poehlsgaard J., & Douthwaite S. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 3, 870-881 (2005
2. Gaynor M., & Mankin A. S. Macrolide antibiotics: binding site, mechanism of action, resistance. Curr. Top. Med. Chem. 3, 949-961 (2003
3. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob. Agents. Chemother. 39, 577-585 (1995
4. Sutcliffe J., & Leclercq R. Mechanisms of resistance to macrolides, lincosamides, and ketolides. in Macrolide Antibiotics, Schönfeld W., & Kirst H. A. (eds) (Birkhäuser Verlag, 2002
5. Cundliffe E. How antibiotic-producing organisms avoid suicide. Annu. Rev. Microbiol. 43, 207-233 (1989
6. Griffith L. J., Ostrander W. E., Mullins C. G., & Beswick D. E. Drug antagonism between lincomycin and erythromycin. Science 147, 746-747 (1965
7. Weisblum B., & Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J. Bacteriol. 98, 447-452 (1969
8. Roberts M. C. Distribution of macrolide, lincosamide, streptogramin, ketolide and oxazolidinone (MLSKO) resistance genes in Gram-negative bacteria. Curr. Drug Targets Infect. Disord. 4, 207-215 (2004
9. Roberts M. C. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol. Lett. 282, 147-159 (2008
10. Ramu H., Mankin A., & Vazquez-Laslop N. Programmed drug-dependent ribosome stalling. Mol. Microbiol. 71, 811-824 (2009
11. Subramanian S. L., Ramu H., & Mankin A. S. Inducible resistance to macrolide antibiotics. In Antibiotic Drug Discovery and Development, Dougherty T. J., & Pucci M. J. (eds) (Springer Publishing Company, 2011
12. Rosato A., Vicarini H., & Leclercq R. Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. J. Antimicrob. Chemother. 43, 559-562 (1999
13. Werckenthin C., & Schwarz S. Molecular analysis of the translational attenuator of a constitutively expressed erm(A) gene from Staphylococcus intermedius. J. Antimicrob. Chemother. 46, 785-788 (2000
14. Schmitz F. J., et al. Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin. J. Antimicrob. Chemother. 49, 611-617 (2002
15. Horinouchi S., & Weisblum B. Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc. Natl Acad. Sci. USA 77, 7079-7083 (1980
16. Shivakumar A. G., Hahn J., Grandi G., Kozlov Y., & Dubnau D. Posttranscriptional regulation of an erythromycin resistance protein specified by plasmic pE194. Proc. Natl Acad. Sci. USA 77, 3903-3907 (1980
17. Vazquez-Laslop N., Thum C., & Mankin A. S. Molecular mechanism of drugdependent ribosome stalling. Mol. Cell 30, 190-202 (2008
18. Andersson D. I., & Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260-271 (2010
19. Depardieu F., Podglajen I., Leclercq R., Collatz E., & Courvalin P. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20, 79-114 (2007
20. Foucault M. L., Depardieu F., Courvalin P., & Grillot-Courvalin C. Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc. Natl Acad. Sci. USA 107, 16964-16969 (2010
21. Maravic G., Feder M., Pongor S., Flogel M., & Bujnicki J. M. Mutational analysis defines the roles of conserved amino acid residues in the predicted catalytic pocket of the rRNA: m6A methyltransferase ErmC?. J. Mol. Biol. 332, 99-109 (2003
22. Novick R. P. Genetic systems in staphylococci. Methods Enzymol. 204, 587-636 (1991
23. Nair D., et al. Whole genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J. Bacteriol. 193, 2332-2335 (2011
24. Vester B., Nielsen A. K., Hansen L. H., & Douthwaite S. ErmE methyltransferase recognition elements in RNA substrates. J. Mol. Biol. 282, 255-264 (1998
25. Kovalic D., Giannattasio R. B., Jin H.-J., & Weisblum B. 23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase. J. Bacteriol. 176, 6992-6998 (1994
26. Maguire B. A. Inhibition of bacterial ribosome assembly: a suitable drug target? Microbiol. Mol. Biol. Rev. 73, 22-35 (2009
27. Ito K., Chiba S., & Pogliano K. Divergent stalling sequences sense and control cellular physiology. Biochem. Biophys. Res. Commun. 393, 1-5 (2010
28. Vázquez-Laslop N., Ramu H., & Mankin A. S. Nascent peptide-mediated ribosome stalling promoted by antibiotics. In Ribosomes: Structure, Function, and Dynamics, Rodnina M. V., Green R., & Wintermeyer W. (eds) (Springer-Verlag, 2011
29. Poole K. Bacterial stress responses as determinants of antimicrobial resistance. J. Antimicrob. Chemother. 67, 2069-2089 (2012
30. Tanner D. R., Cariello D. A., Woolstenhulme C. J., Broadbent M. A., & Buskirk A. R. Genetic identification of nascent peptides that induce ribosome stalling. J. Biol. Chem. 284, 34809-34818 (2009
31. Nakatogawa H., & Ito K. The ribosomal exit tunnel functions as a discriminating gate. Cell 108, 629-636 (2002
32. Cruz-Vera L. R., Rajagopal S., Squires C., & Yanofsky C. Features of ribosome-peptidyl-tRNA interactions essential for tryptophan induction of tna operon expression. Mol. Cell 19, 333-343 (2005
33. Mayford M., & Weisblum B. ermC leader peptide. Amino acid sequence critical for induction by translational attenuation. J. Mol. Biol. 206, 69-79 (1989
34. Chiba S., et al. Recruitment of a species-specific translational arrest module to monitor different cellular processes. Proc. Natl Acad. Sci. USA 108, 6073-6078 (2011
35. Hartz D., McPheeters D. S., Traut R., & Gold L. Extension inhibition analysis of translation initiation complexes. Methods Enzymol. 164, 419-425 (1988
36. Muto H., Nakatogawa H., & Ito K. Genetically encoded but nonpolypeptide prolyl-tRNA functions in the A site for SecM-mediated ribosomal stall. Mol. Cell 22, 545-552 (2006
37. Chiba S., & Ito K. Multisite ribosome stalling: a unique mode of regulatory nascent chain action revealed for MifM. Mol. Cell 47, 863-872 (2012
38. Seidelt B., et al. Structural insight into nascent polypeptide chain-mediated translational stalling. Science 326, 1412-14415 (2009
39. Lawrence M., Lindahl L., & Zengel J. M. Effects on translation pausing of alterations in protein and RNA components of the ribosome exit tunnel. J. Bacteriol. 190, 5862-5869 (2008
40. Weisblum B., Graham M. Y., Gryczan T., & Dubnau D. Plasmid copy number control: isolation and characterization of high-copy-number mutants of plasmid pE194. J. Bacteriol. 137, 635-643 (1979
41. Douthwaite S., Jalava J., & Jakobsen L. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm. Mol. Microbiol. 58, 613-622 (2005
42. Sergiev P. V., Lesnyak D. V., Bogdanov A. A., & Dontsova O. A. Identification of Escherichia coli m2G methyltransferases: II. The ygjO gene encodes a methyltransferase specific for G1835 of the 23 S rRNA. J. Mol. Biol. 364, 26-31 (2006
43. Pfister P., et al. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-4G. Proc. Natl Acad. Sci. USA 102, 5180-5185 (2005
44. Wilson D. N., & Beckmann R. The ribosomal tunnel as a functional environment for nascent polypeptide folding and translational stalling. Curr. Opin. Struct. Biol. 21, 274-282 (2011
45. Zhang G., Hubalewska M., & Ignatova Z. Transient ribosomal attenuation coordinates protein synthesis and co-translational folding. Nat. Struct. Mol. Biol. 16, 274-280 (2009
46. Ciryam P., Morimoto R. I., Vendruscolo M., Dobson C. M., & O?Brien E. P. In vivo translation rates can substantially delay the cotranslational folding of the Escherichia coli cytosolic proteome. Proc. Natl Acad. Sci. USA 110, E132-E140 (2013
47. Vazquez-Laslop N., Ramu H., Klepacki D., Kannan K., & Mankin A. S. The key role of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide. EMBO J. 29, 3108-3117 (2010
48. Fulle S., & Gohlke H. Statics of the ribosomal exit tunnel: implications for cotranslational peptide folding, elongation regulation, and antibiotics binding. J. Mol. Biol. 387, 502-517 (2009
49. McDougal L. K., et al. Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41, 5113-5120 (2003
50. Tenover F. C., et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 44, 108-118 (2006
51. Yansura D. G., & Henner D. J. Use of the Escherichia coli lac repressor and operator to control gene expression in Bacillus subtilis. Proc. Natl Acad. Sci. USA 81, 439-443 (1984
52. Shivakumar A. G., Gryczan T. J., Kozlov Y. I., & Dubnau D. Organization of the pE194 genome. Mol. Gen. Genet. 179, 241-252 (1980
53. Lee C. Y., Buranen S. L., & Ye Z. H. Construction of single-copy integration vectors for Staphylococcus aureus. Gene 103, 101-105 (1991
54. LaMarre J. M., Locke J. B., Shaw K. J., & Mankin A. S. Low fitness cost of the multidrug resistance gene cfr. Antimicrob. Agents Chemother. 55, 3714-3719 (2011
55. Bailey M., Chettiath T., & Mankin A. S. Induction of ermC expression by ?non-inducing? antibiotics. Antimicrob. Agents Chemother. 52, 866-874 (2008
56. Sander P., et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46, 1204-1211 (2002
57. Standards N.C.f.C.L. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard M7-A7 (Clinical and Laboratory Standards Institute, 2006
58. Ohashi H., Shimizu Y., Ying B. W., & Ueda T. Efficient protein selection based on ribosome display system with purified components. Biochem. Biophys. Res. Commun. 352, 270-276 (2007
59. Siibak T., et al. Antibiotic-induced ribosomal assembly defects result from changes in the synthesis of ribosomal proteins. Antimicrob. Agents Chemother. 53, 563-571 (2009
60. Li G., et al. Proteome response of an extraintestinal pathogenic Escherichia coli strain with zoonotic potential to human and chicken sera. J. Proteomics 75, 4853-4862 (2012